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Summary
The recent discoveries of p63 and p73, homologs of the tumor suppressor p53, raised the possibility of a network of these
family members governing cell cycle arrest and apoptosis in response to stress. However, mice lacking p73 show no
tendency for spontaneous tumors, and mutations in p63 or p73 are rare in human tumors, rendering any obligate role of
these genes in cell death and tumor suppression unclear. In an effort to reconcile these incongruent data, we examined
the genetic interactions between p53, p63, and p73 in well-established paradigms of p53-dependent and -independent
T cell death using primary, genetically defined lymphocytes. Our findings challenge the generality of the notion that p63
and p73 are required for p53 function or for apoptosis in T cells.
Introduction various forms of p53-dependent and p53-independent cell
death. The data derived from these studies argue against the
generality of the concepts that p63 and p73 play essential rolesp53 functions as a tumor suppressor and is mutated or dysregu-
lated in virtually all human cancers. Mouse knockout studies in apoptosis and that p53 requires the functions of p63 and p73.
have demonstrated critical roles for p63 and p73 in epithelial
stem cell maintenance (Yang et al., 1999), neurogenesis, in- Results
flammation, and various homeostatic processes (Yang et al.,
2000). The notion that these homologs also, along with p53, To find systems to address the conflicting data surrounding the
p53 homologs and cell death, we took advantage of adoptivefunction as tumor suppressors is supported by a vast amount
of data from cellular models that have implicated p73 and p63 transfer techniques in immune-deficient mice to generate lym-
phocytes of defined genotypes in a nominally wild-type back-in pathways leading to cell death (Agami et al., 1999; Gong et
al., 1999; Irwin et al., 2000; Jost et al., 1997; Osada et al., ground. Such reconstituted lymphocytes could then be probed
for the specific requirement of each p53 homolog in well-defined1998; Yang et al., 1998; Yuan et al., 1999). Related work on the
mechanism of cell death following excessive T cell receptor paradigms of p53-dependent and -independent T cell death
(Clarke et al., 1993; Lowe et al., 1993a).(TCR) activation has argued for an essential role for p73 in
this process (Lissy et al., 2000). Finally, analysis of genetically As an initial step in these studies, we asked if the p53 homo-
logs could be induced in wild-type thymocytes triggered by twodefined, E1A-programmed murine embryonic fibroblasts (MEFs)
calls up functions for p63 and p73 in p53-dependent cell death major death-inducing signals. p53’s requirement for cell death
in thymocytes following ionizing radiation is well established,(Flores et al., 2002). While together these data link p63 and
p73 to tumor suppression, p63 and p73 are generally free of as is its dispensability for glucocorticoid-triggered thymocyte
apoptosis (Clarke et al., 1993; Lowe et al., 1993a). As expected,mutations in human tumors (Kaghad et al., 1997; Osada et al.,
1998; Irwin and Kaelin, 2001), and p73 null mice show no obvi- p53 protein was induced in thymocytes treated with ionizing
radiation but not in response to glucocorticoids (Supplementalous tendency to develop spontaneous tumors (Yang et al.,
2000). The present work examines T cells engineered to have Figure S1A at http://www.cancercell.org/cgi/content/full/6/1/
85/DC1). However, neither treatment gave rise to detectabledefined p53, p63, and p73 genotypes for their ability to undergo
S I G N I F I C A N C E
The advent of the p53 homologs p63 and p73 has triggered intense debate on whether and how they interact with p53 in tumor
suppression. While p63 and p73 are spared mutations in tumors, myriad reports argue that p63 and p73 function autonomously or
in conjunction with p53 to promote cell death. However, from experiments with T cells engineered for precise p63 and p73 genotypes,
we now report that p53 acts alone in some forms of apoptosis, countering the notion that p63 and p73 largely mimic and facilitate
the actions of p53. Our data argue that p53 suppresses cancer independently of p63 and p73 and that neither homolog is likely to
mitigate or complement defects in the p53 gene.
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Figure 2. p53-dependent and -independent thymocyte death
Reconstituted thymocytes were treated with either 5 Gy  irradiation (left
panel) or 1 M dexamethasone (right panel) for indicated times. The bars
represent the average of two independent experiments (shown by white
dots).
V(D)J recombination machinery, which is required to generate
T cell receptor and immunoglobulin genes (Shinkai et al., 1992).
Six weeks after the injection of donor cells into the Rag2/
hosts, we examined two lymphoid organs for their reconstitution
by donor cells. T cell development in the thymus was assessed
by examining the expression of CD4 and CD8 antigens, markers
of helper and cytotoxic T cells, respectively (Figure 1B). Signifi-
cantly, the overall numbers of p63/, p73/, or p63/; p73/
thymocytes in the reconstituted thymi were similar to those
reconstituted with wild-type cells, as were the percentages of
cells that had differentiated into CD4/CD8 double-positive and
CD4 and CD8 single-positive cells (Figures 1B and 1C). The
analyses of T and B cells in splenocytes using TCR and B220,
mature T and B cell markers, respectively, as well as the absolute
numbers of TCR T cells in the spleen of reconstituted
Rag2/ mice, revealed no obvious differences between wild-
Figure 1. Reconstitution of T cell development in RAG2/ mice
type donor cells and those derived from mice lacking one or
A: Overview of the experimental strategy. Fetal liver cells (FLC) from E15.5
more members of the p53 gene family (Figures 1D and 1E).embryos were injected intravenously into sublethally irradiated RAG2/
Thus, the p63 and p73 genotypes of the hematopoietic donormice (107 FLC per reconstitution). Cells from thymus and spleen were ana-
lyzed 6 weeks after reconstitution. cells did not affect T cell development, the number of thymo-
B: CD4 and CD8 expression in reconstituted thymocytes. cytes generated, or their migration to the spleen.
C: Absolute thymocyte number.
With the successful reconstitution of Rag2/ mice by lym-D: TCR and B220 expression in reconstituted spleen cells.
phocytes of defined genotypes, the requirement of p53, p63,E: Absolute TCR T cell number.
Bars in C and E indicate the average number of the cells. and p73 in various models of T cell death could be determined.
Thymocytes having p53/, p63/, p73/, and p63/; p73/
genotypes were isolated from the reconstituted Rag2/ mice
and subjected to various stresses that are known to induce celllevels of p63 or p73 proteins (Supplemental Figures S1B and
death in wild-type cells. Ionizing radiation was used to assessS1C at http://www.cancercell.org/cgi/content/full/6/1/85/DC1),
the involvement of p63 and p73 in p53-dependent cell death,despite our ability to detect transcripts encoding these proteins
and dexamethasone was used to test their role in a p53-inde-using reverse transcription polymerase chain reaction (RT-PCR)
pendent form of cell death. Five hours after exposure to ionizingtechniques (data not shown). It was possible, though, that p63
radiation, the p53 null thymocytes appeared to be only margin-and p73 proteins were induced and active at levels below our
ally more resistant to cell death in comparison to wild-type, p63detection sensitivity, necessitating a genetic approach to defin-
null, p73 null, or the double p63/p73 null cells (Figure 2, lefting their role in T cell death.
panel). By 20 hr, however, the p53 null cells proved to be remark-Analysis of cell-autonomous gene function in lymphocytes
ably resistant to cell death, whereas the other thymocytes havinghas been aided by the use of adoptive transfer in Rag2 null mice,
single or combined losses of the p63 and p73 genes were noas this approach circumvents any systemic defect imparted by
more resistant than the wild-type cells (Figure 2, left panel).the loss of a gene (Washburn et al., 1997). The adoptive transfer
When thymocytes from the same reconstituted mice were testedwas achieved by injecting fetal hematopoietic cells from mice
for their response to dexamethasone, all proved equally sensi-lacking one or more p53 family members into sublethally irradi-
tive over the time examined (Figure 2, right panel). These obser-ated Rag2/ mice (Figure 1A). T or B cells observed in Rag2/
vations in thymocytes argue not only against required rolesmice have the genotype of the donor animal, since the indige-
nous lymphocyte precursors fail to mature due to the lack of for p63 and p73 in p53-dependent apoptosis but also against
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Figure 3. Forward scatter of reconstituted thymocytes
Cells from reconstituted thymi were analyzed by flow cytometry 6 weeks
after transplantation. Shown is one representative data set out of two experi-
ments with similar results. The dotted lines represent wild-type control thymo-
cytes. Note that lymphoblastic appearance of thymocytes of the p53 null
thymocytes is absent in cells lacking p63 and p73.
mutually compensating roles of p63 or p73 in either p53-depen-
dent or p53-independent cell death.
Six weeks following reconstitution of the immune systems
of the Rag2/ mice, none of the p63/, p73/, and p63/p73 Figure 4. Activation-induced cell death in the purified CD4 T cells
null thymocytes showed a “blasting” appearance marked by A: Scheme of the activation-induced cell death (AICD) protocol, which
enhanced cell size, which is common in p53/ thymocytes consists of initial activation and secondary TCR stimulation.
and T cell lymphomas derived from p53/ cells (Figure 3). This B: Forward scatter (FSC) and side scatter (SSC) analysis of wild-type CD4
T cells after the secondary stimulation for the indicated times. Viable cellsfinding suggests that p53 functions independently of p63 and
were gated, and the percentages of those cells are shown on right bottomp73 to suppress the blasting phenotype, at least in a short-term
corner.
experiment employed in this study. C: Annexin V staining. The same set of the cells in B was stained with FITC-
In contrast to thymocyte cell death following DNA damage, conjugated Annexin V, and the percentages of Annexin V-positive cells
were plotted over time (closed circles). The blasting T cells that were cul-cell death in mature T cells following strong T cell receptor
tured in the absence of anti-CD3 mAb served as negative control (openstimulation proceeds in the absence of p53 activity (Boehme
circles).and Lenardo, 1996). However, recent data, primarily from the D: AICD in the purified CD4 T cells that were obtained from reconstituted
established Jurkat T cell line programmed with mutant versions RAG2/ mice. The cells were assayed for apoptosis at 6 hr after secondary
of E2F-1 and p73, as well as unpurified spleen cells from adult stimulation.
p73/ mice, have suggested a role for p73 in activation-induced
cell death (AICD) (Lissy et al., 2000). To clarify and address the
roles of p73 as well as p63 during the process of AICD in T cells
family members that might have been obscured in syngeneicin genetically defined cells, we purified peripheral CD4 T cells
mice due to systemic defects. Overall, our data offer geneticderived from Rag2/ mice reconstituted with hematopoietic
evidence that p63 and p73 are dispensable for both radiation-cells from p63/, p73/, and p63/p73 null mice and analyzed
and glucocorticoid-induced cell death in immature T cells andthose cells in a wild-type environment. Initially, AICD was in-
for AICD in mature T cells. These conclusions place importantduced in the purified wild-type CD4 T cells using a standard
limitations on the generality of data implicating p73 and p63 inregimen of primary and secondary activation and monitored
proapoptotic responses to cellular stress and for the role ofover time using forward- and side-scatter flow cytometer pa-
these genes in p53-mediated cell death, at least as they applyrameters (Figures 4A and 4B). This analysis indicated that 6 hr
to primary immature thymocytes and mature peripheral T cells.of TCR stimulation was sufficient to observe cellular changes
As much of the evidence in favor of a proapoptotic role forconsistent with apoptosis. These primary indicators were then
p73 and p63 has been derived from overexpression studies inconfirmed by fluorescence-activated cell sorting (FACS) analy-
transformed cell lines, the present data argue that further physio-sis of Annexin V staining and propidium iodide exclusion, which
logical experiments may be needed to validate the positive in-supported the observation that 6 hr of stimulation resulted in
fluence of the p53 homologs on cell death. Our finding that therobust AICD (Figure 4C). When the same activation protocol
combined loss of p63 and p73 fails to abrogate p53-dependentwas applied to purified CD4 T cells of the p63/, p73/, or
cell death (Figure 2, left panel) and blasting thymocytes duep63/; p73/ genotypes for 6 hr, the overall percentages of
to a lack of p53 function (Figure 3) appears to contradict theAICD were very similar (Figure 4D), indicating that none of the
conclusions from experiments performed with genetically de-p53 family members was required for the underlying processes
fined MEFs (Flores et al., 2002). However, the MEFs that wereof receptor-mediated T cell apoptosis.
employed in those studies were altered by stable expression
of the E1A oncogene, a commonly used enhancer of apoptoticDiscussion
responses in MEFs (Lowe et al., 1993b). The mechanism by
which E1A promotes cell death in response to stimuli remainsThe Rag2 lymphocyte reconstitution system has revealed im-
portant features of cell-autonomous interactions among p53 incompletely understood but is thought to operate through mul-
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tiple pathways. For instance, the roles of Bax as a downstream dominant-negative species evolved to interfere with the tran-
target of p53 and in chemosensitivity were most clearly revealed scriptional activities of p53. Given the high ratio of expression
in the MEF model employing an E1A background (McCurrach between N-p63 and p53 in keratinocytes (unpublished data),
et al., 1997). Regardless, the apparent requirement of p73 and the prospect exists that p53 activity is suppressed in the basal
p63 in p53-dependent apoptosis in these E1A-expressing cells cells of many epithelial tissues. Indeed, mechanisms appear
might be attributable to the influence of E1A rather than a reflec- to exist in keratinocytes to reverse this ratio that involve p63
tion of the normal function of p63 and p73. More recently, p73 degradation and p53 accumulation in response to DNA damage
has been implicated in the apoptotic response to chemotherapy (Liefer et al., 2000), which might contribute to epithelial cell
in a study that employed H-ras-expressing, p73 null MEFs (Irwin tumors. Similar interactions between p53 and p73 have been
et al., 2003). Altogether, these data raise the intriguing possibility deduced from the loss of sympathetic neurons in the p73 null
that oncogenic signals somehow render p53 pathways depen- mice, a phenotype attributed to the enhanced p53 activity in
dent on p63 and p73 function. As such, it will be important to the absence of N-p73 (Pozniak et al., 2000). Thus, it seems
understand how oncogenic factors might influence the func- that the salient features of interactions between p53, p63, and
tional interactions between p53, p63, and p73 and the extent p73 might be interfering rather than cooperative. Whether these
of such phenomena. An alternative possibility that is raised by three family genes participate in largely independent programs
our work is that p63 and p73 are dispensable for p53-dependent of tumor suppression, stem cell maintenance, and homeostatic
cell death in physiologically relevant situations and that neither control or interact in all three functions will have to await more
p63 nor p73 serves to functionally cover for p53 by triggering detailed genetics and biochemistry.
stress-related cell death. This latter issue is of considerable
Experimental proceduresclinical significance, as much of the work on p73 and p63 has
argued for their p53-like activities and therefore tumor suppres-
Mice and lymphocyte reconstitutionsor functions. Additional experiments have produced data inter-
Knockout mouse lines that were used in this study were backcrossed overpreted to support the concept that p73 and possibly p63 play
ten times on a Balb/c background. The generation of p53/ (Jacks et al.,
important roles in the chemotherapeutic response (Irwin et al., 1994), p63/ (Yang et al., 1999), p73/ (Yang et al., 2000), and RAG2/
2003; Bergamaschi et al., 2003). Moreover, the analysis of radia- (Shinkai et al., 1992) mice has been described previously. For reconstitution
tion-induced neural apoptosis of mouse embryos also impli- experiments, null embryos were derived from matings among p53/ 	
p53/ and p63/; p73/	 p63/; p73/ heterozygotes. For timed matingscates p63 and p73 in p53-mediated cell death (Flores et al.,
to generate staged embryos, the day of the vaginal plug was designated2002). These experiments support the requirement of p63 and
E0.5. At E15.5, fetal livers were removed, and the cells were dissociatedp73 in p53-dependent cell death in the absence of oncogenes
and placed in culture (Roswell Park Memorial Institute [RPMI] medium sup-
and therefore could be reconciled with the data that are pre- plemented with 10% fetal bovine serum), while genotyping was performed
sented here on T cells by invoking cell type specificity for p53 using tail DNA. The wild-type p53 allele was amplified using primers W5

family interactions. It could also be argued that conclusions from and W3
, whereas the knockout allele was amplified using primers M5
 and
the mouse knockout models are obscured by compensatory W3
 (Jacks et al., 1994). The wild-type p63 and p73 alleles were amplified
using primers p63F and p63R and p73F and p73R, respectively, whereasmechanisms that bring to bear new pathways in support of p53-
knockout alleles were amplified using primers Neo and either p63R or p73R.dependent cell death.
The oligonucleotide sequences that were used were as follows. p63F, 5
-It is also difficult to reconcile our data that p73 and p63 are
TTC TCA GAT GGT ACC GCT CC-3
; p63R, 5
-GGT GCT TTG AGG CCC
dispensable for AICD in T cells and those implicating p73 in this GGA TC-3
; p73F, 5
-GGG CCA TGC CTG TCT ACA AGA A-3
; p73R, 5
-
process. AICD is the consequence of excessive T cell receptor CCT TCT ACA CGG ATG AGG TG-3
; and Neo, 5
-GCT AAA GCG CAT
activation and has been shown to be mediated by Fas ligand GCT CCA GAC-3
. During the process of genotyping, 4- to 5-week-old
RAG2/ recipient mice received a single 250 cGy dose of total body (Alderson et al., 1995). Systemic differences between our experi-
irradiation (137Cesium source). Six hours later, the viability of the fetal liverments and those of previous studies that linked p73 to AICD
cells was examined by trypan blue dye exclusion (generally over 95% viable)do exist; most notably, our analysis used purified T cells,
and 1 	 107 viable fetal liver cells with the expected genotypes were injectedwhereas the other studies employed total splenocytes in a p73
i.v. into the recipient mice.
null background. Our data on purified, p73 null CD4 T cells
indicated that they were no more resistant than wild-type con- Immunoblotting
trols up to 24 hr after secondary TCR stimulation (Figure 4D Thymocytes from 3-week-old wild-type mice were treated with 1 M dexa-
and Supplemental Figure S2 at http://www.cancercell.org/cgi/ methasone (Sigma) or 5 Gy  irradiation. Immunoblotting was carried out as
described (Lowe et al., 1993a) with a pool of anti-p53 monoclonal antibodiescontent/full/6/1/85/DC1). Given the inflammatory defects ob-
(mAbs) (PAb421 and PAb240; Oncogene Science), an anti-p63 mAb (cloneserved in the p73 null mice (Yang et al., 2000), it is possible
4A4), and an anti-p73 mAb (clone 11C12) raised against the carboxyl ter-that cytokine abnormalities have confounded the previous anal-
minus of p73 (corresponding to aa 401-636 of the human transactivating
yses of AICD in p73 null mice (Lissy et al., 2000). Regardless, isoform).
any requirement for p73 or p63 in AICD was not apparent from
the present experiments on purified T cells of defined geno- Flow cytometry
The following antibodies were used: fluorescein isothiocyanate (FITC)-types.
anti-CD4 (clone GK1.5), phycoerythrin (PE)-anti-CD8 (clone 53-6.7), PE-Finally, the dispensability of p63 and p73 for T cell death
anti-TCR (clone H57-597), and cychrome (Cyc)-anti-B220/CD45R (clonedoes not preclude interactions among p53 family members,
RA3-6B2) (all from BD Pharmingen). The labeled cells were analyzed on awhich appear to be supported by evolutionary, genetic, and
FACSCalibur machine using the CellQuest software (BD Pharmingen).
biochemical considerations (Yang et al., 2002). Phylogenetic
analyses show the simultaneous appearance of p53 in chordates Apoptosis assay
along with the putative dominant-negative versions of p63 and For thymocyte cell death, the reconstituted thymocytes were treated as
described (Lowe et al., 1993a). The cell viability was determined by ApoAlertp73 (N-p63 and N-p73), suggesting the possibility that the
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Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bron-Annexin V-FITC kit (BD Pharmingen) according to the manufacturer’s proto-
son, R.T., and Weinberg, R.A. (1994). Tumor spectrum analysis in p53-col. For AICD (Boehme et al., 1995; Jones et al., 1990; Rocha and von
mutant mice. Curr. Biol. 4, 1–7.Boehmer, 1991; Russell, 1995), CD4 single-positive T cells were purified
from spleens using CD4 microbeads (Miltenyi Biotec) and were activated Jones, L.A., Chin, L.T., Longo, D.L., and Kruisbeek, A.M. (1990). Peripheral
by placing on anti-CD3 mAb (clone 145-2C11; BD Pharmingen)-coated clonal elimination of functional T cells. Science 250, 1726–1729.
plates in the presence of 4 g/ml anti-CD28 mAb (clone 37.51; Southern
Jost, C.A., Marin, M.C., and Kaelin, W.G., Jr. (1997). p73 is a human p53-Biotec) for 3 days. The activated T cells were then replated in the presence
related protein that can induce apoptosis. Nature 389, 191–194.of interleukin-2 (IL-2) (50 units/106 cells) for 48 hr followed by centrifugation
over Ficoll-Paque (Amersham) to remove dead cells. T cell blasts were Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.-C., Valent, A.,
stimulated by plate-coated anti-CD3mAb in the presence of IL-2 (100 units/ Minty, A., Chalon, P., Lelias, J.-M., Dumont, X., et al. (1997). Monoallelically
106 cells) for the indicated times, and the percentage of apoptotic cells was expressed gene related to p53 at 1p36, a region frequently deleted in neuro-
determined as described above. blastoma and other human cancers. Cell 90, 809–819.
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